Skip to main navigation Skip to search Skip to main content

COVID-19 Clinical Research: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Aprepitant Injectable Emulsion in Early Hospitalized Adult Patients With COVID-19

Project: Research

Project Details

StatusFinished
Effective start/end date08/31/2006/10/22

Funding

  • Heron Therapeutics Inc: $14,270.00